Treatment of Dactylitis and Enthesitis in Psoriatic Arthritis with Biologic Agents: A Systematic Review and Metaanalysis.

Published in: The Journal of rheumatology (2019)

The pooled analysis demonstrated that anti-TNF-α agents have the same efficacy as novel agents (ustekinumab, secukinumab, and ixekizumab) in dactylitis and enthesitis.

Keyphrases

rheumatoid arthritis
juvenile idiopathic arthritis
ankylosing spondylitis
replacement therapy